In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

GSK forms leading consumer health JV with Novartis; later GSK buys out stake

Executive Summary

Creating what Deutsche Bank analysts say will be the top OTC business in the world, GlaxoSmithKline PLC and Novartis AG formed a consumer health joint venture. Ownership will be split 63.5% GSK/36.5% Novartis, with the JV operating under GSK’s GlaxoSmithKline Consumer Healthcare division.
Deal Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Nutraceuticals
    • OTC, Consumer
Deal Status
  • Final
Deal Type
  • Alliance
    • Joint Venture

Related Companies